Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

For: Ahmadi N, Yousefnia H, Bahrami-Samani A, Zolghadri S, Alirezapour B, Ghazi FM. Development of ^186/188Re-Chitosan as an Effective Therapeutic Agent for Rheumatoid Arthritis. Curr Radiopharm 2020;14:154-160. [PMID: 33272191 DOI: 10.2174/1874471013666201203152941] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/24/2020] [Revised: 10/07/2020] [Accepted: 11/22/2020] [Indexed: 11/22/2022]

For:	Ahmadi N, Yousefnia H, Bahrami-Samani A, Zolghadri S, Alirezapour B, Ghazi FM. Development of ^186/188Re-Chitosan as an Effective Therapeutic Agent for Rheumatoid Arthritis. Curr Radiopharm 2020;14:154-160. [PMID: 33272191 DOI: 10.2174/1874471013666201203152941] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/24/2020] [Revised: 10/07/2020] [Accepted: 11/22/2020] [Indexed: 11/22/2022]

Number	Cited by Other Article(s)
1	Preclinical evaluation of 188Re-HYNIC-PSMA as a novel therapeutic agent. J Radioanal Nucl Chem 2022. [DOI: 10.1007/s10967-021-08173-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022] Abstract Collapse Key Words Collapse MESH Headings Collapse Grants Collapse Affiliation(s) Collapse

Number

Cited by Other Article(s)

Preclinical evaluation of 188Re-HYNIC-PSMA as a novel therapeutic agent. J Radioanal Nucl Chem 2022. [DOI: 10.1007/s10967-021-08173-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]